Regeneron Shares Fall Following BMO's Note Of Roche Preference By: Benzinga via Benzinga June 20, 2014 at 12:14 PM EDT Shares of Regeneron Pharmaceuticals (NASDAQ: REGN) are down three percent following BMO analyst Jim Birchenough's note of customers ... Read More >> Related Stocks: Bank of Montreal Regeneron Pharmaceuticals